JNJ

189.06

+1.45%↑

ABT

124.63

+0.17%↑

TMO

556.32

-0.37%↓

ISRG

529.81

-1.42%↓

DHR

214.87

+0.44%↑

JNJ

189.06

+1.45%↑

ABT

124.63

+0.17%↑

TMO

556.32

-0.37%↓

ISRG

529.81

-1.42%↓

DHR

214.87

+0.44%↑

JNJ

189.06

+1.45%↑

ABT

124.63

+0.17%↑

TMO

556.32

-0.37%↓

ISRG

529.81

-1.42%↓

DHR

214.87

+0.44%↑

JNJ

189.06

+1.45%↑

ABT

124.63

+0.17%↑

TMO

556.32

-0.37%↓

ISRG

529.81

-1.42%↓

DHR

214.87

+0.44%↑

JNJ

189.06

+1.45%↑

ABT

124.63

+0.17%↑

TMO

556.32

-0.37%↓

ISRG

529.81

-1.42%↓

DHR

214.87

+0.44%↑

Search

Penumbra Inc

Gesloten

SectorGezondheidszorg

231.3 -0.77

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

229.91

Max

235.85

Belangrijke statistieken

By Trading Economics

Inkomsten

6M

45M

Verkoop

15M

339M

K/W

Sectorgemiddelde

65.78

37.003

Winstmarge

13.336

Werknemers

4,500

EBITDA

1.9M

51M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+32.45% upside

Dividenden

By Dow Jones

Volgende Winsten

5 nov 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

758M

9.7B

Vorige openingsprijs

232.07

Vorige sluitingsprijs

231.3

Nieuwssentiment

By Acuity

50%

50%

168 / 373 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bearish Evidence

Penumbra Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

30 okt 2025, 23:32 UTC

Populaire aandelen

Stocks to Watch: Amazon, Reddit, SPS Commerce

30 okt 2025, 23:02 UTC

Winsten

AIA Group 3Q Value of New Business Grew

30 okt 2025, 23:45 UTC

Marktinformatie

Gold Edges Higher Amid Prospects of Continued Central-Bank Demand -- Market Talk

30 okt 2025, 23:00 UTC

Winsten

Amazon Posts 13% Revenue Jump, Strong Cloud Sales -- 3rd Update

30 okt 2025, 22:59 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Global Equities Roundup: Market Talk

30 okt 2025, 22:59 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Mineral Resources Bear Reckons Lithium Assets May Be Dressed Up For Sale -- Market Talk

30 okt 2025, 22:56 UTC

Marktinformatie

Australia Shares Shaping to Pare Recent Losses -- Market Talk

30 okt 2025, 22:35 UTC

Winsten

AIA Group 3Q Value of New Business Margin Was 58.2%, Up 5.7 Ppt on Year >1299.HK

30 okt 2025, 22:35 UTC

Winsten

AIA Group 3Q Value of New Business $1.48B Vs. $1.16B>1299.HK

30 okt 2025, 22:31 UTC

Winsten

Apple Expects Big December Quarter on iPhone Upgrades -- 2nd Update

30 okt 2025, 22:29 UTC

Winsten

Amazon Posts 13% Revenue Jump, Strong Cloud Sales -- 2nd Update

30 okt 2025, 22:27 UTC

Winsten

Minas Buenaventura 3Q EPS 66c >BVN

30 okt 2025, 22:27 UTC

Winsten

Minas Buenaventura 3Q Rev $431M >BVN

30 okt 2025, 22:27 UTC

Winsten

Minas Buenaventura 3Q Net $179M >BVN

30 okt 2025, 22:16 UTC

Marktinformatie
Winsten

Amazon's Grocery Delivery Business Gains Ground -- Market Talk

30 okt 2025, 22:14 UTC

Winsten

Review & Preview: A Tech Earnings Storm -- Barrons.com

30 okt 2025, 22:00 UTC

Winsten
Acquisities, Fusies, Overnames

The Day Pharma's Weight-Loss Gold Rush Intensified -- WSJ

30 okt 2025, 21:39 UTC

Winsten

Amazon Stock Jumps on Earnings Beat. AWS Is Doing Fine. -- Barrons.com

30 okt 2025, 21:26 UTC

Winsten

Amazon Stock Jumps on Earnings Beat. AWS Is Doing Fine. -- Barrons.com

30 okt 2025, 21:14 UTC

Marktinformatie
Winsten

Apple Sees Record Quarterly Services Revenue -- Market Talk

30 okt 2025, 21:09 UTC

Marktinformatie
Winsten

Global Equities Roundup: Market Talk

30 okt 2025, 21:09 UTC

Marktinformatie
Winsten

Amazon Says One-Off Costs Ate Into Operating Income -- Market Talk

30 okt 2025, 21:04 UTC

Winsten

Apple Expects Big December Quarter on iPhone Upgrades -- Update

30 okt 2025, 21:03 UTC

Winsten

Eldorado Gold 3Q Gold Sales Were 116,529 Ounces at Avg Realized Gold Price Per Ounce Sold of $3,527 >ELD.T

30 okt 2025, 21:03 UTC

Winsten

Eldorado Gold 3Q Gold Production Was 115,190 Ounces >ELD.T

30 okt 2025, 21:00 UTC

Winsten

Eldorado Gold Skouries on Track for 1Q of 2026

30 okt 2025, 21:00 UTC

Winsten

Eldorado Gold 3Q Adj EPS 41c >EGO

30 okt 2025, 21:00 UTC

Winsten

Eldorado Gold 3Q Rev $434.7M >EGO

30 okt 2025, 21:00 UTC

Winsten

Eldorado Gold 3Q Net $56M >EGO

30 okt 2025, 21:00 UTC

Winsten

Eldorado Gold 3Q EPS 27c >EGO

Peer Vergelijking

Prijswijziging

Penumbra Inc Prognose

Koersdoel

By TipRanks

32.45% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 309.11 USD  32.45%

Hoogste 350 USD

Laagste 266 USD

Gebaseerd op 12 Wall Street-analisten die 12-maands prijsdoelen bieden voor Penumbra Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

12 ratings

10

Buy

2

Hold

0

Sell

Technische score

By Trading Central

288.28 / 292.9394Steun & Weerstand

Korte Termijn

Bearish Evidence

Gemiddeld Termijn

Bullish Evidence

Lange Termijn

Weak Bullish Evidence

Sentiment

By Acuity

168 / 373 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
help-icon Live chat